If your weight-loss medication has come from a compounding pharmacy, a change worth understanding is underway. In 2026 the FDA moved to permanently exclude semaglutide and tirzepatide — the active ingredients in the major GLP-1 medications — from the list of drugs that large-scale facilities are allowed to compound in bulk. The agency's reasoning: the earlier shortages that justified mass compounding have largely resolved, and FDA-approved versions are now available.
Why This Is Happening
During the shortages of recent years, compounded GLP-1s filled a real gap. But the FDA has raised specific safety concerns about some compounded products — in particular so-called "salt forms" such as semaglutide sodium, which are chemically distinct from the versions studied in clinical trials and were never proven safe and effective in people. As the approved supply stabilized, the FDA proposed winding down large-scale compounding altogether.
What It Means for You
- Your access may changeSome pharmacies and telehealth sellers have already scaled back or stopped producing compounded GLP-1s. If you rely on one, it is worth knowing where your medication comes from.
- Not all sources are equalWhere the medication is made, and in what chemical form, matters. This is exactly the kind of detail a supervising physician should be able to answer for you.
- This is not a reason to panic — or to stopStopping a GLP-1 abruptly has its own consequences. The right move is a plan, not a scramble.
How We Think About It at Tera Fe
Our position has not changed with the headlines: a GLP-1 is a medical tool, not a mail-order shortcut. Before we prescribe one, we run a full hormonal and metabolic workup, because willpower is rarely the real problem — biology usually is. And we monitor you along the way, so the medication is doing what it should without costing you muscle or nutrition. You can read more about our approach to medical weight management.
What to Do Now
If you are on a compounded GLP-1 and unsure about your source or your plan, that is a conversation worth having with a physician rather than a website. Take our 3-minute quiz, learn more in Dr. Allen's book, Why Do I Feel Like This?, or book a consultation to review your options with our team.
This article reflects publicly reported FDA actions in 2026 and is for education only; it is not medical or legal advice. Regulations continue to evolve — talk with your own clinician about your specific medication.